News
Friday, 22 September 2017
A secondary analysis of a phase III randomised trial was performed. The initial trial was comparing capecitabine and oxaplatin with or without lapatinib for treatment of advanced gastroesophageal cancer.
Publication Date:
Wednesday, August 30, 2017 - 13:00
Good news in the field of malaria treatment in South Africa. Garsun® (artesunate; from Equity Pharmaceuticals) is now registered in South Africa.
Publication Date:
Wednesday, August 30, 2017 - 13:00
With little evidence that failing to complete a prescribed antibiotic course contributes to resistance, it’s time to drop this message, argue Martin Llewelyn et al in a piece in the BMJ last month.
Publication Date:
Wednesday, August 30, 2017 - 12:45
The American Society of Clinical Oncology (ASCO) recently published updated guidelines for the use of antiemetics in cancer patients receiving chemotherapy and radiation therapy.
Publication Date:
Tuesday, August 1, 2017 - 16:30